PHLDA1 contributes to hypoxic ischemic brain injury in neonatal rats via inhibiting FUNDC1-mediated mitophagy

Xiao-Lu Jiang1,2,3, Zu-Bin Zhang4,5, Chen-Xi Feng1

  • 1Pediatrics Research Institute, Children's Hospital of Soochow University, Suzhou, 215025, China.

PubMed

Insights

Pleckstrin homology-like domain family A member 1 (PHLDA1) exacerbates neonatal brain injury after hypoxia-ischemia (HI). PHLDA1 inhibits mitophagy, worsening neuronal damage, while its knockdown offers neuroprotection.

Area of Science:

  • Neuroscience
  • Cell Biology
  • Pathology

Background:

  • Neonatal brain injury is frequently caused by hypoxia-ischemia (HI).
  • Mitophagy, the process of degrading damaged mitochondria, is crucial for cell survival following HI.
  • Pleckstrin homology-like domain family A member 1 (PHLDA1) is involved in cellular processes like apoptosis and oxidative stress.

Purpose of the Study:

  • To investigate the role of PHLDA1 in hypoxia-ischemia (HI)-induced neuronal injury in neonates.
  • To explore the mechanisms by which PHLDA1 regulates mitophagy in the context of neonatal brain injury.

Main Methods:

  • Established a hypoxia-ischemia (HI) model in newborn rats.
  • Utilized primary hippocampal neurons subjected to oxygen and glucose deprivation/reoxygenation (OGD/R) in vitro.
  • Employed lentiviral vectors for PHLDA1 knockdown and overexpression, and utilized mitophagy inhibitor Mdivi-1 and FUNDC1 knockdown.

Main Results:

  • PHLDA1 expression was significantly upregulated in HI-induced neonatal brain injury models and OGD/R-treated neurons.
  • PHLDA1 knockdown ameliorated neuronal injury and improved cognitive function in HI rats, while overexpression worsened outcomes.
  • PHLDA1 knockdown enhanced mitophagy by activating FUNDC1, which was essential for its neuroprotective effects.

Conclusions:

  • PHLDA1 plays a detrimental role in neonatal hypoxia-ischemia (HI) brain injury.
  • PHLDA1 contributes to injury by inhibiting FUNDC1-mediated mitophagy.
  • Targeting PHLDA1 may offer a therapeutic strategy for neonatal brain injury.

Related Concept Videos